Impromune®, the new product boosting immune system performance by the Veterinary Division of Bioibérica
13 Dec 2011
Companion Animal Health
IMPROMUNE® improves the innate as well as the adaptive response of the immune system of cats and dogs
IMPROMUNE® contains AHCC and Nucleoforce, a unique combination of proven synergistic effects which has been patented for small animals. IMPROMUNE® is recommended for cats and dogs with immunosuppressive disorders such as infections, immune system stress or hypoproteinemia, or that are receiving immunosuppressive drug treatment.
This new product opens up a new field of action for the Veterinary Division of Bioibérica: that of Immunology.
For further information, please visit www.bioiberica.es or www.veterinaria.bioiberica.es
Related News
27 May 2020
Companion Animal Health
- This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
- The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®
7 Apr 2020
Companion Animal Health
- The study, carried out at the University of Florida, supports the use of this new formulation of sphingolipids and glycosaminoglycans as a strategy to improve skin health in patients with canine atopic dermatitis
5 Mar 2020
Companion Animal Health
- The fourth Iberzoo Propet will be held from 5 to 7 March at the Feria de Madrid
- Klorexivet®, Prolivet® and Condrovet Force HA® are scientifically proven products that bring value added for veterinarians